Dil Ltd - 506414 - Compliance Certificate Under Regulation 40(9) Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated October 11, 2019 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year ended September 30, 2019. Dil Ltd - 506414 - Compliance Certificate For The Period April 1, 2019 To September 30, 2019
Compliance Certificate - Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2019 to September 30, 2019 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058. Dil Ltd - 506414 - Shareholding for the Period Ended September 30, 2019
Dil Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here DIL LTD. - 506414 - Intimation Regarding Change Of Name From DIL Limited To Fermenta Biotech Limited Pursuant To 'Scheme Of Amalgamation Of Fermenta Biotech Limited (The Transferor Company) With DIL Limited (The Transferee Company) And Their Respective Shareholders Under Sections 230 To 232 And Other Applicable Provisions Of The Companies Act, 2013 (Scheme Of Amalgamation)'
Intimation regarding change of name from DIL Limited to Fermenta Biotech Limited pursuant to 'Scheme of Amalgamation of Fermenta Biotech Limited (the Transferor Company) with DIL Limited (the Transferee Company) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Scheme of Amalgamation)' We wish to inform that pursuant to the National Company Law Tribunal order dated September 19, 2019 sanctioning the Scheme of Amalgamation and vide the Certificate of Incorporation issued by Registrar of Companies, Mumbai dated October 17, 2019, name of the Company has been changed from DIL Limited to Fermenta Biotech Limited with effect from October 17, 2019. Application for necessary approval from BSE Limited for the same shall be made in due course. Kindly take the above on record. Dil Ltd - 506414 - Intimation Regarding Change Of Name From DIL Limited To Fermenta Biotech Limited Pursuant To 'Scheme Of Amalgamation Of Fermenta Biotech Limited (The Transferor Company) With DIL Limited (The Transferee Company) And Their Respective Shareholders Under Sections 230 To 232 And Other Applicable Provisions Of The Companies Act, 2013 (Scheme Of Amalgamation)'
Intimation regarding change of name from DIL Limited to Fermenta Biotech Limited pursuant to 'Scheme of Amalgamation of Fermenta Biotech Limited (the Transferor Company) with DIL Limited (the Transferee Company) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Scheme of Amalgamation)' We wish to inform that pursuant to the National Company Law Tribunal order dated September 19, 2019 sanctioning the Scheme of Amalgamation and vide the Certificate of Incorporation issued by Registrar of Companies, Mumbai dated October 17, 2019, name of the Company has been changed from DIL Limited to Fermenta Biotech Limited with effect from October 17, 2019. Application for necessary approval from BSE Limited for the same shall be made in due course. Kindly take the above on record. Dil Ltd - 506414 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- SRIKANT N SHARMADesignation :- Company Secretary and Compliance Officer DIL LTD. - 506414 - Announcement under Regulation 30 (LODR)-Allotment
Intimation about the Allotment of 637,537 equity shares (New Securities) of the face value of INR.5/- (Rupees Five only) each, fully paid-up to the members of Fermenta Biotech Limited, as on the Record Date pursuant to the Scheme of Amalgamation: The Committee of Board of Directors of the Company have issued and allotted 637,537 equity shares (New Securities) of the face value of Rs. 5/- (Rupees Five only) each, fully paid-up, to the members of Fermenta Biotech Limited, as on the Record Date of October 10, 2019, as per the exchange ratio in terms of the Scheme. Consequent to the said allotment of New Securities, the paid-up share capital of the Company has increased From: 91,72,792 equity shares of Rs. 5/- each, amounting to Rs. 4,58,63,960 To: 98,10,329 equity shares of Rs. 5/- each amounting to Rs. 4,90,51,645 An application will be made for listing and trading approval of BSE Limited for the above New Securities in due course. DIL LTD. - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with Investors and Analysts on Thursday, October 10, 2019 and Friday, October 11, 2019. This is to further inform that the Investor Presentation 'August 2019' to be shared with Investors in the above interaction, has been uploaded on the website of the Company - www.dil.net and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company. Dil Ltd - 506414 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) is closed with effect from October 1, 2019 till 48 hours after the declaration of financial results for the quarter ended September 30, 2019, as approved at the Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be made in due course. Dil Ltd - 506414 - Publication Of Notice Of 'Record Date'
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation vide letter dated September 26, 2019 regarding outcome of Board Meeting dated September 26, 2019, we are enclosing herewith photocopy of the newspaper publications published in Financial Express, English (All Editions) and Loksatta, Marathi (All Editions) dated September 28, 2019 for your reference and record.